Investing.com - Silk Road Medical (NASDAQ: SILK) reported fourth quarter EPS of $-0.34, $0.04 better than the analyst estimate of $-0.38. Revenue for the quarter came in at $40.1M versus the consensus estimate of $37.35M.
Silk Road Medical's stock price closed at $52.99. It is down -0.49% in the last 3 months and up 44.98% in the last 12 months.
Silk Road Medical saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Silk Road Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Silk Road Medical's Financial Health score is "fair performance".
Check out Silk Road Medical's recent earnings performance, and Silk Road Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar